As of 30 Sep 2025, 22 institutional investors reported holding 4,121,251 shares of NUVATION BIO INC - *W EXP 02/10/202 (NUVBWS).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 4,121,251 | $4,551,610 | -$162,707 | $0.20 | 22 |
| 2025 Q2 | 4,054,762 | $2,924,777 | -$5,922 | $0.27 | 20 |
| 2025 Q1 | 1,785,778 | $266,747 | -$3,906 | $0.20 | 10 |
| 2024 Q4 | 3,472,082 | $798,578 | -$14,912 | $0.23 | 20 |
| 2024 Q3 | 3,432,264 | $333,938 | -$20,947 | $0.10 | 18 |
| 2024 Q2 | 3,596,243 | $575,400 | +$112,045 | $0.16 | 19 |
| 2024 Q1 | 2,877,266 | $872,947 | +$42,360 | $0.30 | 18 |
| 2023 Q4 | 2,867,565 | $172,053 | -$4,776 | $0.06 | 16 |
| 2023 Q3 | 3,051,085 | $303,753 | -$14,871 | $0.10 | 19 |
| 2023 Q2 | 3,207,792 | $527,690 | -$24,868 | $0.17 | 18 |
| 2023 Q1 | 389,909 | $47,000 | -$296 | $0.12 | 1 |
| 2022 Q4 | 392,369 | $57,000 | $0 | $0.15 | 1 |
| 2022 Q3 | 3,297,126 | $638,000 | $0 | $0.20 | 16 |
| 2022 Q2 | 392,369 | $110,000 | -$265 | $0.28 | 1 |
| 2022 Q1 | 393,316 | $318,000 | +$4,385 | $0.80 | 2 |
| 2021 Q4 | 387,893 | $733,000 | +$32,992 | $1.89 | 2 |
| 2021 Q3 | 3,569,065 | $9,191,000 | -$65,363 | $2.56 | 23 |
| 2021 Q2 | 3,619,384 | $9,429,000 | -$197,297 | $2.60 | 23 |
| 2021 Q1 | 4,159,614 | $11,088,000 | +$10,964,009 | $2.67 | 28 |